BRCA1 and ovarian carcinoma: Compared to the lifetime risk of developing breast (12.9%) and ovarian cancer (2.7%) in the general population, female carriers of pathogenic BRCA1 mutations are at a significantly higher risk of developing these cancers [2,3].